Search Within

Neeta Pandit-Taskar

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (74)
  2. Journal Article (69)
  3. Book Section (2)
Groups
  1. GSK Faculty (145)
  2. Molecular Imaging and Therapy Service (145)
  3. Radiology, Department of (145)
  4. Molecular Pharmacology and Chemistry Program Faculty (103)
  5. Sloan Kettering Institute Faculty (103)
  6. Medical Physics (83)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (61)
  3. Jason Lewis (52)
  4. Nai-Kong Cheung (48)
  5. Serge Lyashchenko (48)
  6. Pat Zanzonico (46)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (6)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Journal of Nuclear Medicine (28)
  3. Neuro-Oncology (13)
  4. Pediatric Blood and Cancer (13)
  5. Clinical Cancer Research (11)
  6. European Journal of Nuclear Medicine and Molecular Imaging (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Society of Nuclear Medicine (28)
  3. Springer (20)
  4. American Association for Cancer Research (15)
  5. Oxford University Press (14)
  6. Wiley Periodicals, Inc (13)

More Publishers

Results (145)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-humans imaging with (89)Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: Preliminary pharmacokinetics, biodistribution, and lesion targeting
    Journal Article

    Pandit-Taskar, N.; Postow, M. A.; Hellmann, M. D.; Harding, J. J.; Barker, C. A.; O'Donoghue, J. A.; Ziolkowska, M.; Ruan, S.; Lyashchenko, S. K.; Tsai, F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Biodistribution and dosimetry of intraventricularly administered (124)I-omburtamab in patients with metastatic leptomeningeal tumors
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Kramer, K.; Grkovski, M.; Fung, E. K.; Shi, W.; Zhang, Z.; Lyashchenko, S. K.; Fung, A. M.; Pentlow, K. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Retooling a blood-based biomarker: Phase I assessment of the high-affinity CA19-9 antibody HuMAB-5B1 for immuno-PET imaging of pancreatic cancer
    Journal Article

    Lohrmann, C.; O'Reilly, E. M.; O'Donoghue, J. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Lyashchenko, S. K.; Ruan, S.; Teng, R.; Scholz, W.; Maffuid, P. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Imaging patients with metastatic castration-resistant prostate cancer using (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody
    Journal Article

    Carrasquillo, J. A.; Fine, B. M.; Pandit-Taskar, N.; Larson, S. M.; Fleming, S. E.; Fox, J. J.; Cheal, S. M.; O'Donoghue, J. A.; Ruan, S.; Ragupathi, G.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular 131I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Donzelli, M.; Suzanne, W.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M.; Greenfield, J.; Carrasquillo, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A phase I study of convection-enhanced delivery of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma: An update with dose-response assessment
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zhou, Z.; Zanzonico, P.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save